Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
asset management company
|
| gptkbp:AUM |
Over $6 billion (as of 2023)
|
| gptkbp:CEO |
gptkb:Robin_John
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
ESG investing
Ethical investing Values-based investing |
| gptkbp:founded |
2008
|
| gptkbp:foundedBy |
gptkb:Robin_John
Finny Kuruvilla |
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Eventide Asset Management
|
| gptkbp:industry |
Financial services
Asset management |
| gptkbp:notableInvestment |
Eventide Dividend Opportunities Fund
Eventide Gilead Fund Eventide Healthcare & Life Sciences Fund |
| gptkbp:offersProduct |
Mutual funds
Investment strategies |
| gptkbp:regulates |
gptkb:U.S._Securities_and_Exchange_Commission
|
| gptkbp:website |
https://www.eventidefunds.com/
|
| gptkbp:bfsParent |
gptkb:Casma_Therapeutics
|
| gptkbp:bfsLayer |
7
|